You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

466 Results
Drug
Other Name(s): Sutent®
Sep 2023
Drug
Other Name(s): Casodex® (multiple brands available)
Apr 2024
Drug
Nov 2024
Drug
Other Name(s): Treanda®
Nov 2024
Drug
Other Name(s): Adcetris®
Jun 2025
Drug
Other Name(s): Bosulif®
Nov 2024
Drug
Other Name(s): Blincyto®
Nov 2025
Drug
Other Name(s): Sylvant®
Mar 2025
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Palliative
Funding:
Exceptional Access Program
    SUNItinib - Unresectable or metastatic/recurrent Gastrointestinal Stromal Tumour, with specific criteria
Oct 2020
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Jul 2024

Pages